Related Experiment Video
Updated: Feb 18, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
Biomarkers to Predict Cardiovascular Death
Devinder S Dhindsa1, Jay Khambhati1, Pratik B Sandesara1
1Division of Cardiology, Department of Medicine, Emory University School of Medicine, 1462 Clifton Road Northeast, Suite 507, Atlanta, GA 30322, USA.
Insights
Biomarkers help identify individuals at high risk for cardiovascular death, especially those with heart disease. A multimarker approach combined with clinical factors improves risk assessment for sudden cardiac death.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Risk Stratification
Background:
- Cardiovascular diseases remain a leading cause of mortality worldwide.
- Accurate identification of individuals at high risk for cardiovascular death is crucial for timely intervention.
- Biomarkers offer potential for improved risk assessment beyond traditional clinical factors.
Purpose of the Study:
- To review current biomarkers for identifying individuals at increased risk of cardiovascular death.
- To evaluate the evolving role of biomarkers in risk stratification for sudden cardiac death.
- To assess the utility of multimarker strategies in different patient populations.
Main Methods:
- Systematic review of published literature on cardiovascular biomarkers and risk prediction.
- Analysis of studies focusing on general population, coronary artery disease (CAD), and heart failure cohorts.
- Evaluation of multimarker strategies incorporating circulating proteins and clinical risk factors.
Main Results:
- Biomarkers have demonstrated efficacy in identifying elevated cardiovascular death risk across diverse populations.
- A multimarker strategy, combining protein measures and clinical factors, shows promise for near-term risk prediction in established CAD.
- The cost-effectiveness of applying similar multimarker strategies to the general population requires further investigation.
Conclusions:
- Biomarker-based risk stratification is a valuable tool in cardiovascular medicine.
- Multimarker approaches, particularly in patients with coronary artery disease, enhance the identification of individuals at high risk for mortality.
- Further research is needed to determine the clinical and economic benefits of widespread biomarker use for cardiovascular risk assessment in the general population.
Abstract:
This article reviews biomarkers that have been shown to identify subjects at increased risk for cardiovascular death within the general population, in those with established coronary artery disease, and in those with heart failure. Use of biomarkers for risk stratification for sudden cardiac death continues to evolve. It seems that a multimarker strategy for risk stratification using simple measures of circulating proteins and usual clinical risk factors, particularly in patients with known coronary artery disease, can be used to identify patients at near-term risk of death. Whether similar strategies in the general population will prove to be cost-effective needs to be investigated.
More Related Videos
10:03Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
07:25Predicting Amputation using Local Circulating Mononuclear Progenitor Cells in Angioplasty-treated Patients with Critical Limb Ischemia
Published on: September 22, 2020
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies
Coronary Artery Disease I: Introduction
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...